These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17060685)

  • 1. Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.
    Videhult P; Laurell G; Wallin I; Ehrsson H
    Exp Biol Med (Maywood); 2006 Nov; 231(10):1638-45. PubMed ID: 17060685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
    Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
    Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics and cytotoxicity of cisplatin and its monohydrated complex.
    Yachnin JR; Wallin I; Lewensohn R; Sirzén F; Ehrsson H
    Cancer Lett; 1998 Oct; 132(1-2):175-80. PubMed ID: 10397471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the safety of metal-based drugs by tuning their metabolism with chemoprotective agents.
    Gailer J
    J Inorg Biochem; 2018 Feb; 179():154-157. PubMed ID: 29137811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical basis for the detoxification of cisplatin-derived hydrolysis products by sodium thiosulfate.
    Sooriyaarachchi M; Gailer J; Dolgova NV; Pickering IJ; George GN
    J Inorg Biochem; 2016 Sep; 162():96-101. PubMed ID: 27324827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the acid dissociation constant for cis-diammineaquachloroplatinum(II) ion. A hydrolysis product of cisplatin.
    Andersson A; Hedenmalm H; Elfsson B; Ehrsson H
    J Pharm Sci; 1994 Jun; 83(6):859-62. PubMed ID: 9120821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of zebrafish for assessing ototoxic and otoprotective agents.
    Ton C; Parng C
    Hear Res; 2005 Oct; 208(1-2):79-88. PubMed ID: 16014323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cisplatin and its monohydrated complex in humans.
    Andersson A; Fagerberg J; Lewensohn R; Ehrsson H
    J Pharm Sci; 1996 Aug; 85(8):824-7. PubMed ID: 8863271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
    Li G; Liu W; Frenz D
    Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
    Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
    Harned TM; Kalous O; Neuwelt A; Loera J; Ji L; Iovine P; Sposto R; Neuwelt EA; Reynolds CP
    Clin Cancer Res; 2008 Jan; 14(2):533-40. PubMed ID: 18223229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abiotic degradation of methyl parathion in anoxic sulfur-containing system mediated by natural organic matter.
    Liao X; Zhang C; Wang Y; Tang M
    Chemosphere; 2017 Jun; 176():288-295. PubMed ID: 28273536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
    Feghali JG; Liu W; Van De Water TR
    Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of myeloperoxidase in the inner ear of cisplatin-treated guinea pigs.
    Watanabe K; Yagi T
    Anticancer Drugs; 2000 Oct; 11(9):727-30. PubMed ID: 11129735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
    Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
    Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decomposition kinetics of cisplatin in human biological fluids.
    Nagai N; Okuda R; Kinoshita M; Ogata H
    J Pharm Pharmacol; 1996 Sep; 48(9):918-24. PubMed ID: 8910854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.